India


RCEP talks: Heat on India to scrap import duty on 90 per cent of goods
New Delhi is wary of giving access to China to its market
Two major cooperatives ask government to keep dairy sector outside FTA negotiations purview
The country’s two major dairy cooperatives have urged the government to keep dairy products outside the ongoing trade negotiations with various blocs including hugely milk surplus regions.
Vodafone Group serves second notice on India to formally start 2nd arbitration in tax case
Vodafone Group Plc has served its second notice on the Indian government to formally commence the​second ​arbitration in the high profile Rs 22,000 crore tax matter.
Withdrawal from investment treaties: An omen for waning investor protection in Asia-Pacific?
While India and Indonesia may have withdrawn from existing BITs, this does not necessarily leave foreign investors without any protection.
India-Chile expanded PTA to come into effect tomorrow
Chile is the fourth-largest trading partner of India in the LAC (Latin America and Caribbean) region after Brazil, Venezuela and Argentina.
Kerala govt wants Centre to consult it on RCEP treaty
The CPI(M)-led LDF government in Kerala wants the Centre to consult it before signing the RCEP agreement, saying it would have adverse impact on state agriculture
ISDS is unsuited to meet today’s global challenges
The growing number of investor claims against sovereign host states has fuelled a backlash against bilateral investment treaties and free-trade agreements across the world.
Aus, NZ trying to corner India in Oceania
One of Prime Minister Narendra Modi’s most insightful, if low key, foreign policy initiatives was to work to deepen relations with more than a dozen island nations of Oceania.
RCEP will hurt local industry and allow workers’ exploitation, says civil society
RCEP is being negotiated in secrecy, but it is likely to favour big companies and threaten India’s agriculture, industry and e-commerce sectors
MSF response on RCEP negotiations in the Philippines
Negotiators must protect public health safeguards that enable developing countries like India to keep supplying life-saving affordable medicines for millions of people worldwide.